|
Biosense Webster Inc EZ Steer ThermoCool NAV; Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
|
Back to Search Results |
|
| Catalog Number |
BNI75TCDFH |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Cardiac Tamponade (2226)
|
| Date of Event |
07/30/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient underwent an idiopathic ventricular tachycardia ablation procedure with an ez steer thermocool nav catheter and the patient experienced cardiac tamponade which required pericardiocentesis.Toward the end of the premature ventricular contraction ablation, it was noticed that the patient had developed a pericardial effusion on intracardiac echocardiogram.At one point, the patient's blood pressure dropped significantly.A pericardiocentesis was performed to drain the effusion, and the patient's blood was "auto-transfused." the patient's blood pressure recovered, they were stable and awake when case was completed.Because of the volume of blood that was transfused, the decision was made to transport the patient to the surgical unit.Current patient status was stable.Multiple attempts have been made to obtain clarification to this complaint.However, no further information has been made available.
|
| |
|
Additional Manufacturer Narrative
|
|
D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The bwi product analysis lab received the device for evaluation on 25-aug-2026.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number:(b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|